Clinical Sites h1 >
Cedars Sinai Medical Center
Duke University Medical Center
Durham, North Carolina 27710-1000
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
Closed
8202: Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (ADAPT-teleMG)
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis is a pilot study designed to better understand the use of modified clinical assessments during telehealth visits for patients with Myasthenia Gravis. A total of 50 adult participants with confirmed diagnosis of MG, with a range of disease severity will be enrolled across sites.
George Washington University - Administrative Core
Washington, District of Columbia 20037
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
Closed
8202: Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (ADAPT-teleMG)
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis is a pilot study designed to better understand the use of modified clinical assessments during telehealth visits for patients with Myasthenia Gravis. A total of 50 adult participants with confirmed diagnosis of MG, with a range of disease severity will be enrolled across sites.
Massachusetts General Hospital
Boston, Massachusetts 02114
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
Closed
8202: Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (ADAPT-teleMG)
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis is a pilot study designed to better understand the use of modified clinical assessments during telehealth visits for patients with Myasthenia Gravis. A total of 50 adult participants with confirmed diagnosis of MG, with a range of disease severity will be enrolled across sites.
Medical University of South Carolina
Charleston, South Carolina 29464
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
University of California Irvine
Orange, California 92868
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
University of Chicago
Chicago, Illinois 60637
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
Closed
8202: Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (ADAPT-teleMG)
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis is a pilot study designed to better understand the use of modified clinical assessments during telehealth visits for patients with Myasthenia Gravis. A total of 50 adult participants with confirmed diagnosis of MG, with a range of disease severity will be enrolled across sites.
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27599-7025
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
Wake Forest School of Medicine
Winston-Salem, North Carolina 27157
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
Yale School of Medicine
New Haven, Connecticut 06510
Recruiting
8201: Explore MG 2
EXPLORE MG 2 is a natural history study designed to better understand disease characteristics and identify treatment predictive and responsive biomarkers for myasthenia gravis. A total of 300-400 participants with confirmed diagnosis of myasthenia gravis are expected to be enrolled in the study.
Closed
8202: Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (ADAPT-teleMG)
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis is a pilot study designed to better understand the use of modified clinical assessments during telehealth visits for patients with Myasthenia Gravis. A total of 50 adult participants with confirmed diagnosis of MG, with a range of disease severity will be enrolled across sites.